Corvus Pharmaceuticals Inc’s filing revealed that its President and CEO MILLER RICHARD A MD acquired Company’s shares for reported $1.0 million on May 06 ’24. In the deal valued at $1.73 per share,577,634 shares were bought. As a result of this transaction, MILLER RICHARD A MD now holds 577,634 shares worth roughly $0.97 million.
Then, Jones William Benton bought 20,000 shares, generating $34,624 in total proceeds. Upon buying the shares at $1.73, the insider now owns 153,773 shares.
Before that, Grais Linda bought 10,000 shares. Corvus Pharmaceuticals Inc shares valued at $24,500 were divested by the Director at a price of $2.45 per share. As a result of the transaction, Grais Linda now holds 10,000 shares, worth roughly $16800.0.
Oppenheimer initiated its Corvus Pharmaceuticals Inc [CRVS] rating to an Outperform in a research note published on August 18, 2023; the price target was $7. Cantor Fitzgerald began covering CRVS with “an Overweight” recommendation on May 27, 2021. Mizuho revised its rating on February 10, 2021. It rated CRVS as “a Neutral” which previously was an “a Buy”.
Price Performance Review of CRVS
On Tuesday, Corvus Pharmaceuticals Inc [NASDAQ:CRVS] saw its stock fall -12.04% to $1.68. Over the last five days, the stock has gained 8.39%. Corvus Pharmaceuticals Inc shares have fallen nearly -4.55% since the year began. Nevertheless, the stocks have risen 40.00% over the past one year. While a 52-week high of $4.19 was reached on 02/09/24, a 52-week low of $1.05 was recorded on 04/18/24. SMA at 50 days reached $1.7898, while 200 days put it at $1.7960. A total of 0.95 million shares were traded, compared to the trading of 0.38 million shares in the previous session.
Levels Of Support And Resistance For CRVS Stock
The 24-hour chart illustrates a support level at 1.4267, which if violated will result in even more drops to 1.1733. On the upside, there is a resistance level at 1.9367. A further resistance level may holdings at 2.1933. The Relative Strength Index (RSI) on the 14-day chart is 50.79, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.2510, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 51.90%. Stochastics %K at 68.27% indicates the stock is a holding.
The most recent change occurred on September 12, 2019 when Mizuho began covering the stock and recommended ‘”a Buy”‘ rating.
